Literature DB >> 12170394

Cost-effective recognition and diagnosis of dementia.

David S Geldmacher1.   

Abstract

Alzheimer's disease (AD) has the potential to become the most overwhelming public health concern of this century due to increasing life expectancy and growth in the aging population. As a result, primary care physicians and neurologists will be seeing a greater number of elderly patients in their practice and will subsequently be expected to both identify and initiate treatment in those individuals who may display signs of dementia and related neurologic conditions. There is good evidence that AD is underrecognized or undercoded in primary care settings. Underrecognition is an important problem in this population because early treatment and counseling have been shown to provide benefits to both patients and caregivers. As their patient population ages, physicians need to learn to recognize the early symptoms of AD and make a diagnosis in order to provide cost-effective therapies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170394     DOI: 10.1055/s-2002-33049

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  7 in total

1.  Alzheimer's disease: a healthcare burden of epidemic proportion.

Authors:  T S Dharmarajan; Srinivas G Gunturu
Journal:  Am Health Drug Benefits       Date:  2009-01

2.  Assessing attitudes and behaviours surrounding Alzheimer's disease in Europe: key findings of the Important Perspectives on Alzheimer's Care and Treatment (IMPACT) survey.

Authors:  R W Jones; J Mackell; K Berthet; S Knox
Journal:  J Nutr Health Aging       Date:  2010-08       Impact factor: 4.075

3.  BRAINCODE for Cognitive Impairment Diagnosis in Older Adults: Designing a Case-Control Pilot Study.

Authors:  Pedro Rocha; Paulina Clara Dagnino; Ronan O'Sullivan; Aureli Soria-Frisch; Constança Paúl
Journal:  Int J Environ Res Public Health       Date:  2022-05-09       Impact factor: 4.614

4.  Cost-effectiveness of post-diagnosis treatment in dementia coordinated by Multidisciplinary Memory Clinics in comparison to treatment coordinated by general practitioners: an example of a pragmatic trial.

Authors:  E J Meeuwsen; P German; R J F Melis; E M Adang; G A Golüke-Willemse; P F Krabbe; B J de Leest; F H J M van Raak; C J M Schölzel-Dorenbos; M C Visser; C A Wolfs; S Vliek; M G M Olde Rikkert
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

Review 5.  Application of pet imaging to diagnosis of Alzheimer's disease and mild cognitive impairment.

Authors:  James M Noble; Nikolaos Scarmeas
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

6.  Detecting Dementia Through Interactive Computer Avatars.

Authors:  Hiroki Tanaka; Hiroyoshi Adachi; Norimichi Ukita; Manabu Ikeda; Hiroaki Kazui; Takashi Kudo; Satoshi Nakamura
Journal:  IEEE J Transl Eng Health Med       Date:  2017-09-15       Impact factor: 3.316

7.  Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial.

Authors:  Els J Meeuwsen; René J F Melis; Geert C H M Van Der Aa; Gertie A M Golüke-Willemse; Benoit J M De Leest; Frank H J M Van Raak; Carla J M Schölzel-Dorenbos; Desiree C M Verheijen; Frans R J Verhey; Marieke C Visser; Claire A Wolfs; Eddy M M Adang; Marcel G M Olde Rikkert
Journal:  BMJ       Date:  2012-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.